Intracellular and extracellular thiol/disulfide homeostasis in bacterial sepsis
Journal of Turkish Clinical Biochemistry · 2022
DOI: 10.56615/tkbd.2022.01 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Turkish Clinical Biochemistry, 2022. Verfasst von Gamze Avcıoğlu und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Themen: Sepsis
Abstract (Originalsprache)
Aim
Many mediators and biomarkers play a role in the pathogenesis of bacterial sepsis (BS) which is still not fully illimunated.The aim was to analyze intracellular oxidised glutathione (GSSG)/reduced glutathione (GSH) and serum thiol/disulfide (extracellular) homeostasis tests in BS to evaluate the contribution of oxidative stress to pathogenesis. Material and Methods: A total of 92 individuals, including 49 patients and 43 healthy volunteers, were included in the present study. The cases who had high probability of BS criteria defined by the third international consensus definitions for sepsis and septic shock and positive blood culture were included in the study. The blood samples were used for intracellular and extracellular thiol/disulfide homeostasis tests.
Results
When BS and control group were compared, GSH, total glutathione (GSH+GSSG), disulfide, Index-3, native thiol and total thiol levels were significantly lower in BS group compared to control group (p
Zitieren
APA
Avcıoğlu, G., Otal, Y., & Erel, Ö. (2022). Intracellular and extracellular thiol/disulfide homeostasis in bacterial sepsis. Journal of Turkish Clinical Biochemistry. https://doi.org/10.56615/tkbd.2022.01
Vancouver
Avcıoğlu G, Otal Y, Erel Ö. Intracellular and extracellular thiol/disulfide homeostasis in bacterial sepsis. Journal of Turkish Clinical Biochemistry. 2022. doi:10.56615/tkbd.2022.01
BibTeX
@article{Avcolu2022,
author = {Avcıoğlu, Gamze and Otal, Yavuz and Erel, Özcan},
title = {Intracellular and extracellular thiol/disulfide homeostasis in bacterial sepsis},
journal = {Journal of Turkish Clinical Biochemistry},
year = {2022},
doi = {10.56615/tkbd.2022.01}
}
EUVIMED